# GLYCOPYRROLATE

NDC: 75834-193
Generic name: glycopyrrolate
Labeler / Manufacturer: Nivagen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20211025

FDA application: ANDA212591

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75834-193"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75834-193
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177